Literature DB >> 11123014

Osteoarthritis.

L S Simon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 11123014     DOI： 10.1007/s11926-999-0024-2

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.592


× No keyword cloud information.
  10 in total

1.  Field test of the reproducibility of automated measurements of medial tibiofemoral joint space width derived from standardized knee radiographs.

Authors:  S A Mazzuca; K D Brandt; J C Buckland-Wright; K A Buckwalter; B P Katz; J A Lynch; R J Ward; C L Emsley
Journal:  J Rheumatol       Date:  1999-06       Impact factor: 4.666

Review 2.  Thirty-six years in the clinic without an MMP inhibitor. What hath collagenase wrought?

Authors:  R A Greenwald
Journal:  Ann N Y Acad Sci       Date:  1999-06-30       Impact factor: 5.691

Review 3.  Radiographic assessment. Introduction: existing methodology.

Authors:  L C Rovati
Journal:  Osteoarthritis Cartilage       Date:  1999-07       Impact factor: 6.576

Review 4.  Viscosupplementation therapy with intra-articular hyaluronic acid. Fact or fantasy?

Authors:  L S Simon
Journal:  Rheum Dis Clin North Am       Date:  1999-05       Impact factor: 2.670

5.  The SF-36 Arthritis-Specific Health Index (ASHI): I. Development and cross-validation of scoring algorithms.

Authors:  J E Ware; S D Keller; H T Hatoum; S X Kong
Journal:  Med Care       Date:  1999-05       Impact factor: 2.983

6.  The SF-36 Arthritis-Specific Health Index (ASHI): II. Tests of validity in four clinical trials.

Authors:  S D Keller; J E Ware; H T Hatoum; S X Kong
Journal:  Med Care       Date:  1999-05       Impact factor: 2.983

7.  The SF-36 Health Survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: relative validity of scales in relation to clinical measures of arthritis severity.

Authors:  M Kosinski; S D Keller; J E Ware; H T Hatoum; S X Kong
Journal:  Med Care       Date:  1999-05       Impact factor: 2.983

8.  The SF-36 Health Survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: tests of data quality, scaling assumptions and score reliability.

Authors:  M Kosinski; S D Keller; H T Hatoum; S X Kong; J E Ware
Journal:  Med Care       Date:  1999-05       Impact factor: 2.983

Review 9.  Clinical trials design: structure modifying agents for osteoarthritis. Future guidelines: areas for development.

Authors:  N Bellamy
Journal:  Osteoarthritis Cartilage       Date:  1999-07       Impact factor: 6.576

Review 10.  Clinical trials of a stromelysin inhibitor. Osteoarthritis, matrix metalloproteinase inhibition, cartilage loss, surrogate markers, and clinical implications.

Authors:  R L Leff
Journal:  Ann N Y Acad Sci       Date:  1999-06-30       Impact factor: 5.691
  10 in total
  9 in total

Review 1.  Efficacy of mesenchymal stem cells injection for the management of knee osteoarthritis: a systematic review and meta-analysis.

Authors:  Peng Xia; Xiaoju Wang; Qiang Lin; Xueping Li
Journal:  Int Orthop       Date:  2015-05-06       Impact factor: 3.075

Review 2.  Current use of autologous adipose tissue-derived stromal vascular fraction cells for orthopedic applications.

Authors:  Jaewoo Pak; Jung Hun Lee; Kwang Seung Park; Moonhee Park; Lin-Woo Kang; Sang Hee Lee
Journal:  J Biomed Sci       Date:  2017-01-31       Impact factor: 8.410

3.  Effectiveness of a single intra-articular bone marrow aspirate concentrate (BMAC) injection in patients with grade 3 and 4 knee osteoarthritis.

Authors:  George S Themistocleous; George D Chloros; Ioannis M Kyrantzoulis; Ioannis A Georgokostas; Marios S Themistocleous; Panayiotis J Papagelopoulos; Olga D Savvidou
Journal:  Heliyon       Date:  2018-10-18

4.  Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: long-term follow up of a multicenter randomized controlled clinical trial (phase I/II).

Authors:  José María Lamo-Espinosa; Gonzalo Mora; Juan F Blanco; Froilán Granero-Moltó; Jorge María Núñez-Córdoba; Silvia López-Elío; Enrique Andreu; Fermín Sánchez-Guijo; José Dámaso Aquerreta; José María Bondía; Andrés Valentí-Azcárate; María Del Consuelo Del Cañizo; Eva María Villarón; Juan Ramón Valentí-Nin; Felipe Prósper
Journal:  J Transl Med       Date:  2018-07-31       Impact factor: 5.531

Review 5.  Cartilage Regeneration in Human with Adipose Tissue-Derived Stem Cells: Current Status in Clinical Implications.

Authors:  Jaewoo Pak; Jung Hun Lee; Wiwi Andralia Kartolo; Sang Hee Lee
Journal:  Biomed Res Int       Date:  2016-01-06       Impact factor: 3.411

6.  Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: multicenter randomized controlled clinical trial (phase I/II).

Authors:  José M Lamo-Espinosa; Gonzalo Mora; Juan F Blanco; Froilán Granero-Moltó; Jorge M Nuñez-Córdoba; Carmen Sánchez-Echenique; José M Bondía; Jesús Dámaso Aquerreta; Enrique J Andreu; Enrique Ornilla; Eva M Villarón; Andrés Valentí-Azcárate; Fermín Sánchez-Guijo; María Consuelo Del Cañizo; Juan Ramón Valentí-Nin; Felipe Prósper
Journal:  J Transl Med       Date:  2016-08-26       Impact factor: 5.531

7.  Intra-articular Hyaluronic Acid (HA) and Platelet Rich Plasma (PRP) injection versus Hyaluronic acid (HA) injection alone in Patients with Grade III and IV Knee Osteoarthritis (OA): A Retrospective Study on Functional Outcome.

Authors:  C Saturveithan; G Premganesh; S Fakhrizzaki; M Mahathir; K Karuna; K Rauf; H William; H Akmal; N Sivapathasundaram; K Jaspreet
Journal:  Malays Orthop J       Date:  2016-07

8.  Mesenchymal Stem Cells in Combination with Hyaluronic Acid for Articular Cartilage Defects.

Authors:  Lang Li; Xin Duan; Zhaoxin Fan; Long Chen; Fei Xing; Zhao Xu; Qiang Chen; Zhou Xiang
Journal:  Sci Rep       Date:  2018-07-02       Impact factor: 4.379

Review 9.  Cartilage Regeneration in Humans with Adipose Tissue-Derived Stem Cells and Adipose Stromal Vascular Fraction Cells: Updated Status.

Authors:  Jaewoo Pak; Jung Hun Lee; Natalie Pak; Yoon Pak; Kwang Seung Park; Jeong Ho Jeon; Byeong Chul Jeong; Sang Hee Lee
Journal:  Int J Mol Sci       Date:  2018-07-23       Impact factor: 5.923
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.